These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 210866)

  • 21. Humoral and cellular immune response during the growth of an SV40 induced tumour in hamsters.
    de Vaux Saint-Cyr C; Loisillier F; Zuinghedau J
    Ann Microbiol (Paris); 1977 Oct; 128(3):385-98. PubMed ID: 203215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Resorption of primary tumors induced by virus SV40 in immunized animals].
    Deĭchman GI; Kliuchareva TE
    Vestn Akad Med Nauk SSSR; 1966; 21(9):12-8. PubMed ID: 4298832
    [No Abstract]   [Full Text] [Related]  

  • 23. Suppression of SV40 T antigen in transformed hamster cells by chronic treatment with 5-bromo-2-deoxyuridine.
    Kreider JW; Del Villano B; Shoff WH; Davidson EA
    Cancer Res; 1972 Oct; 32(10):2148-55. PubMed ID: 4343009
    [No Abstract]   [Full Text] [Related]  

  • 24. Morphologic variations of a cell strain transformed by simian papovavirus SV40 and cloned serially.
    Pauluzzi S; Merletti L; Piras A
    Boll Ist Sieroter Milan; 1973; 52(5):458-67. PubMed ID: 4363058
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of SV40 virus oncogenesis in hamsters. II. The effect of thymectomy on induction of tumor resistance by SV40-transformed human cells.
    Girardi AJ; Roosa RA
    J Immunol; 1967 Dec; 99(6):1217-20. PubMed ID: 4294651
    [No Abstract]   [Full Text] [Related]  

  • 26. Demonstration of SV40-related tumour antigen in human meningiomas by different hamster SV40-T-antisera.
    Zimmermann W; Schernick S; Geissler E; Nisch G
    Acta Virol; 1981 Jul; 25(4):199-204. PubMed ID: 6116413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inability of antiserum active in antibody-dependent cellular cytotoxicity and arming tests to protect against simian virus 40 tumor cell challenge.
    Prather SO; Geller RW; Lausch RN
    J Natl Cancer Inst; 1979 May; 62(5):1273-7. PubMed ID: 220449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific simian virus 40 (SV40)-induced immunity against transplantable SV40 tumor in Syrian hamsters: abrogation by BCG vaccination.
    Zhalgasbayeva GT; Deichman GI
    J Natl Cancer Inst; 1977 Apr; 58(4):1121-4. PubMed ID: 191624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development in hamsters of antibodies against surface antigens present in cells transformed by papovavirus SV40.
    Tevethia SS; Couvillionla ; Rapp F
    J Immunol; 1968 Feb; 100(2):358-62. PubMed ID: 4295750
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the peripheral lymphocytes in the course of the immune response to transplanted SV40-transformed tumour cells in hamsters.
    Nekvasil M; Pekárek J
    Immunology; 1974 Jul; 27(1):159-61. PubMed ID: 4368371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the involvement of cytolytic macrophages in rejection of SV40-induced tumors.
    Chapes SK; Gooding LR
    J Immunol; 1985 Sep; 135(3):2192-8. PubMed ID: 2991384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen.
    Bright RK; Beames B; Shearer MH; Kennedy RC
    Cancer Res; 1996 Mar; 56(5):1126-30. PubMed ID: 8640771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biologic properties of viable deletion mutants of simian virus 40 (SV40) rescued from the cells of an SV40-induced hamster lymphocytic leukemia.
    Diamandopoulos GT; Carmichael G
    J Natl Cancer Inst; 1983 Dec; 71(6):1319-26. PubMed ID: 6317936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of host age, virus dose, and route of inoculation on tumor incidence, latency, and morphology in Syrian hamsters inoculated intravenously with oncogenic DNA simian virus 40.
    Diamandopoulos GT; McLane MF
    J Natl Cancer Inst; 1975 Aug; 55(2):479-82. PubMed ID: 169379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inoculation of simian virus 40 into pregnant hamsters can induce tumors in offspring.
    Rachlin J; Wollmann R; Dohrmann G
    Lab Invest; 1988 Jan; 58(1):26-30. PubMed ID: 2826880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific viral antigens in rat cells transformed by herpes simplex virus type 2 and in rat tumors induced by inoculation of transformed cells.
    Macnab JC; Visser L; Jamieson AT; Hay J
    Cancer Res; 1980 Jun; 40(6):2074-9. PubMed ID: 6245808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitogenic and antimitogenic transforming growth factors secreted by adenovirus 2- and simian virus 40-transformed hamster cells: possible roles in promoting tumorigenesis.
    Akagi K; Murai K; Haddada H; Levine AS; Patch CT
    Cancer Res; 1987 Aug; 47(15):4086-92. PubMed ID: 3038307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of hamster tumors induced by simian virus 40 small t deletion mutants as true histiocytic lymphomas.
    Carbone M; Lewis AM; Matthews BJ; Levine AS; Dixon K
    Cancer Res; 1989 Mar; 49(6):1565-71. PubMed ID: 2538229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative aspects of immunization against primary SV40-induced tumours.
    Kaliev J
    Neoplasma; 1970; 17(4):373-6. PubMed ID: 4319125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.